We recently compiled a list of the 15 Stocks That Will Go to The Moon According to Analysts. In this article, we are going to ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target of ...

In a report released today, Uy Ear from Mizuho Securities reiterated a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report), with a ...

The increasing occurrence of genetic disorders is a major factor fueling the demand for oligonucleotide synthesis, as these molecules are essential for gene therapies and diagnostics aimed at ...

Entrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...

Dyne Therapeutics Inc.-0.93% $1.42B ...

Nasdaq 100 E-Mini futures (NQH25) are trending up +0.77% this morning, rebounding from yesterday’s losses, while investors ...

Following a more than two-year-long hold, Entrada Therapeutics can get its Duchenne muscular dystrophy candidate back on ...

Ramadan often presents a security challenge in Jerusalem, but this may be greater this year given the ongoing seven-front war and Operation Iron Wall in the West Bank. Information ...

Ukraine has reportedly agreed on the terms of a major minerals deal with the US, and President Trump said he was expecting his Ukrainian counterpart Volodymyr Zelensky in Washington to sign the deal ...